Poland· PL-100176345
Prolastin
A proteinase inhibitors product containing alfa-1-proteinasi inhibitor humanus, registered in Poland by Grifols Deutschland GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- alfa-1-Proteinasi inhibitor humanus
- Manufacturer
- Grifols Deutschland GmbH
- Country
- Poland (PL)
- ATC code
- B02AB
- ATC class
- Proteinase inhibitors
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990048090
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a944b7a0-8827-4b09-887e-eb2b2cc65393 GET /v1/drugs/a944b7a0-8827-4b09-887e-eb2b2cc65393?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "1000 mg",
"packaging": "05909990048090 ¦ Rp ¦ 35991\n1 fiol. proszku ¦ 1 fiol. 40 ml rozp. + 1 łącznik Mix2Vial",
"substance": "alfa-1-Proteinasi inhibitor humanus 1000 mg",
"common_name": "alfa-1-Proteinasi inhibitor humanus",
"pl_product_id": "100176345",
"pozwolenie_nr": "12858",
"auth_procedure": "MRP",
"authorisation_validity": "2030-12-15"
}See everything about alfa-1-proteinasi inhibitor humanus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.